3. Swift AE. Ciguatera. J Toxicol - Clin Toxicol. 1993;31:1–29. [PubMed] 4. Gillespie NC. Ciguatera in Australia. Occurrence, clinical features, pathophysiology and management. Med J Austr. 1986;145:584–590. [PubMed] 5. Lehane L. Ciguatera: recent advances but the risk remains. Int J Food Microbiol. 2000;61:91–125. [PubMed]
6. Fleming LE. ciguatera fish poisoning. Shoreman’s Travel Medicine Monthly. 1997;1:1–5.
7. Baden D. In: Marine toxins. deWolff FA, editor. Vol. 21 Elsevier Press; Amsterdam: 1995.
8. Lewis RJ. The changing face of ciguatera. Toxicon. 2001;39:97–106. [PubMed] 9. Lawrence DN. Ciguatera fish poisoning in Miami. J Am Med Assoc. 1980;244:254–258. [PubMed]
10. McKee D. Physician diagnosis and reporting of ciguatera fish poisoning in an endemic area. Harmful Algal Blooms. 2001:451–453.
11. Begier E. Outbreak bias in illness reporting and case confirmation in ciguatera fish poisoning Surveillance in South Florida. Pub Health Rep. 2006;121:658–665. [PMC free article] [PubMed]
12. Nicholson GM. Ciguatoxins: cyclic polyether modulators of voltage-gated ion channel function. Mar Drugs. 2006;4:88–118.
13. Arias HR. Marine toxins targeting ion channels. Mar Drugs. 2006;4:37–69.
14. Cameron J. Electrophysiological studies on ciguatera poisoning in man (Part II) J Neurol Sci. 1991;101:93–97. [PubMed] 15. Bagnis R. Clinical aspects of ciguatera (fish poisoning) in French Polynesia. Hawaii Med J. 1968;28:25–28. [PubMed] 16. Bagnis R. Clinical observations on 3,009 cases of ciguatera (fish poisoning) in the South Pacific. Am J Trop Med Hyg. 1979;28:1067–1073. [PubMed] 17. Withers NW. Ciguatera fish poisoning. Ann Rev Med. 1982;33:97–111. [PubMed]
18. Yasumoto T. Symposium on Seafood Toxins from Tropical Regions. Tohoku University Japan; 1984. p. 74.
19. Steidinger K. Toxic marine dinoflagellates. Academic Press; Orlando: 1985.
20. Calvert GM. Treatment of ciguatera fish poisoning with amitriptyline and nifedipine. J Toxicol - Clin Toxicol. 1987;25:423–428. [PubMed] 21. Naar JP. Brevetoxins, like ciguatoxins, are potent ichthyotoxic neurotoxins that accumulate in fish. Toxicon. 2007;50:707–723. [PMC free article] [PubMed] 22. Flewelling l. Red tide and marine mammal mortalities. Nature. 2005;435:755–756. [PMC free article] [PubMed] 23. Friedman MA. Neuropsychological study of ciguatera fish poisoning: A longitudinal case-control study. Arch Clin Neuropsychol. 2007;22:545–553. [PubMed]
24. Arena P. A pilot study of the cognitive and psychological correlates of chronic ciguatera poisoning. Harmful Algae. 2004;3:51–60.
25. Quod JP. Ciguatera in Reunion Island (SW Indian Ocean): epidemiology and clinical patterns. Toxicon. 1996;34:779–785. [PubMed]
26. Bagnis R. In: Progress in venom and toxin research. Gopalakrishnakone P, editor. National University of Singapore; Singapore: 1987. pp. 372–384.
27. Lewis R. Ciguatera management. SPC Live Reef Fish Information Bulletin. 2000;7:11–13.
28. Bagnis R. In: Algal toxins in seafood and drinking water. Falconer I, editor. Academic Press; London: 1993. pp. 105–115.
29. Chateau-Degat ML. Prevalence of chronic symptoms of ciguatera disease in French Polynesian adults. Am J Trop Med Hyg. 2007;77:842–846. [PubMed] 30. Kodama AM. Variations in symptomatology of ciguatera poisoning. Toxicon. 1989;27:593–595. [PubMed] 31. Chan TY. Chronicity of neurological features in ciguatera fish poisoning. Hum Exp Toxicol. 2001;20:426–428. [PubMed] 32. Blythe DG. Clinical experience with i.v. Mannitol in the treatment of ciguatera. Bull Soc Pathol Exotique. 1992;85:425–426. [PubMed]
33. Benoit E. Reversal of Pacific ciguatoxin-1B effects on myelinated axons by agents used in ciguatera treatment. Cybium. 2000;24:33–40.
34. Chan TY. Life-threatening bradycardia and hypotension in a patient with ciguatera fish poisoning. Trans Roy Soc Trop Med Hyg. 1993;87:71. [PubMed]
35. Ruff RL. Clinical aspects of ciguatera: an overview. Memoirs of the Queensland Museum. 1994:609–619.
36. Glaziou P. Study of factors that influence the clinical response to ciguatera fish poisoning. Bull Soc Pathol Exotique. 1992;85:419–420. [PubMed] 37. Ting JY. Ciguatera poisoning: a global issue with common management problems. Europ J Emerg Med. 2001;8:295–300. [PubMed] 38. Bagnis RA. [Neurologic complications of ciguatera] Bull Soc Pathol Exotique. 1977;70:89–93. [PubMed] 39. Bottein Dechraoui M-Y. Biomonitoring of ciguatoxin exposure in mice using blood collection cards. Toxicon. 2005;46:243–251. [PubMed] 40. Bottein Dechraoui MY. Optimization of ciguatoxin extraction method from blood for Pacific ciguatoxin (P-CTX-1) Toxicon. 2007;49:100–105. [PubMed] 41. Ryan JC. Transcriptional profiling of whole blood and serum protein analysis of mice exposed to the neurotoxin Pacific Ciguatoxin-1. NeuroToxicol. 2007;28:1099–1109. [PubMed]
42. Stinn JF. GIS in public health, 3rd National Conference; San Diego, CA. 2000.
43. Dickey R. Monitoring brevetoxins during a Gymnodinium breve red tide: comparison of sodium channel specific cytotoxicity assay and mouse bioassay for determination of neurotoxic shellfish toxins in shellfish extracts. Nat Toxins. 1999;7:157–165. [PubMed] 44. Manger RL. Detection of sodium channel toxins: directed cytotoxicity assays of purified ciguatoxins, brevetoxins, saxitoxins, and seafood extracts. J AOAC Int. 1995;78:521–527. [PubMed]
45. Dickey R. In: Seafood and Freshwater Toxins: Pharmacology, Physiology, and Detection. 2. Botana LM, editor. Taylor and Francis (CRC Press); 2008. pp. 479–500.
46. Dechraoui MY. Ciguatoxins and brevetoxins, neurotoxic polyether compounds active on sodium channels. Toxicon. 1999;37:125–143. [PubMed] 47. Bottein Dechraoui MY. Use of two detection methods for discriminating ciguatoxins from brevetoxins: application to Great Barracuda from Florida. Toxicon. 2005;46:261–270. [PubMed] 48. Pottier I. Identification of slow and fast-acting toxins in highly ciguatoxic barracuda (Sphyraene barracuda) by HPLC/MS and radiolabelled ligand binding. Toxicon. 2003;42:663–672. [PubMed] 49. Hamilton B. Multiple ciguatoxins present in Indian Ocean reef fish. Toxicon. 2002;40:1347–1353. [PubMed] 50. Lombet A. Ciguatoxin and brevetoxins share a common receptor site on the neuronal voltage-dependent Na+ channel. FEBS Lett. 1987;219:355–359. [PubMed] 51. Darius HT. Ciguatera risk assessment in two toxic sites of French Polynesia using the receptor-binding assay. Toxicon. 2007;50:612–626. [PubMed] 52. Lewis RJ. HPLC/tandem electrospray mass spectrometry for the determination of Sub-ppb levels of Pacific and Caribbean ciguatoxins in crude extracts of fish. Anal Chem. 1999;71:247–250. [PubMed] 53. Hamilton B. Isolation and characterisation of Indian Ocean ciguatoxin. Toxicon. 2002;40:685–693. [PubMed]
54. Lewis J. In: Manual on harmful marine microalgae. Hallegraeff GM, editor. UNESCO; Paris: 2004. pp. 1–22. IOC Manuals and Guides No. 33.
55. Hokama Y. Simplified solid-phase membrane immunobead assay (MIA) with monoclonal anti-ciguatoxin antibody (MAb-CTX) for detection of ciguatoxin and related polyether toxins. J Nat Tox. 1998;7:1–21. [PubMed] 56. Wong CK. Study of an outbreak of ciguatera fish poisoning in Hong Kong. Toxicon. 2005;46:563–571. [PubMed]
57. Dickey R. Evaluation of a solid-phase immunobead assay for detection of ciguatera-related biotoxins in Caribbean finfish. Memoirs of the Queensland Museum. 1994;34:481–488.
58. Hirama M. Total synthesis of ciguatoxin CTX3C. Science. 2001;294:1904–1907. [PubMed]
59. Murata M. Structures and configurations of ciguatoxin from the moray eel Gymnothorax javanicus and its likely precursor from the dinoflagellate Gambierdiscus toxicus. J Am Chem Soc. 1990;112:4380–4386.
60. Murata M. Structures of ciguatoxin and its congener. J Am Chem Soc. 1989;111:8929–8931.
61. Crouch RC. Improvements in the Sensitivity of Inverse-Detected Heteronuclear Correlation Spectra Using Micro Inverse Probes and Micro Cells: HMQC and HMBC Spectra of Caribbean Ciguatoxin -- Preliminary Structural Inferences. Tetrahedron Lett. 1995;36:6827–6830.
62. Vernoux JP. Isolation and characterisation of Caribbean ciguatoxins from the horse-eye jack (Caranx latus) Toxicon. 1997;35:889–900. [PubMed] 63. Lewis RJ. Purification and characterization of ciguatoxins from moray eel (Lycodontis javanicus, Muraenidae) Toxicon. 1991;29:1115–1127. [PubMed] 64. Schnorf H. Ciguatera fish poisoning: a double-blind randomized trial of mannitol therapy. Neurology. 2002;58:873–880. [PubMed] 65. Bagnis R. [Evaluation of the efficacy of mannitol in the treatment of ciguatera in French Polynesia] Med Tropicale. 1992;52:67–73. [PubMed]
66. Blythe DG. In: Foodborne Disease Handbook. Hui YH, editor. Marcel Dekker; New York, NY: 2001. pp. 311–320.
67. Palafox NA. Successful treatment of ciguatera fish poisoning with intravenous mannitol. J Am Med Assoc. 1988;259:2740–2742. [PubMed]
68. Blythe DG. Mannitol Therapy for acute and chronic ciguatera fish poisoning. Memoirs of the Queensland Museum. 1994;34
69. Birinyi-Strachan LC. Neuroprotectant effects of iso-osmolar d-mannitol to prevent Pacific ciguatoxin-1 induced alterations in neuronal excitability: A comparison with other osmotic agents and free radical scavengers. Neuropharmacol. 2005;49:669–686. [PubMed]
70. Lewis R. In: Ciguatera (fish poisoning) Williamson JA, editor. University of New South Wales Press; Sydney: 1996.
71. Pearn JH. Ciguatera and mannitol: experience with a new treatment regimen. Medical Journal of Australia. 1989;151:77–80. [PubMed]
72. Watters MR. In: Marine neurotoxins as a starting point to drugs. Botana LM, editor. Taylor and Francis (CRC Press); 2007.
73. Berlin RM. Symptomatic improvement of chronic fatigue with fluoxetine in ciguatera fish poisoning. Med J Austr. 1992;157:567. [PubMed] 74. Lange WR. Travel and ciguatera fish poisoning. Arch Int Med. 1992;152:2049–2053. [PubMed] 75. Davis RT. Symptomatic improvement with amitriptyline in ciguatera fish poisoning. New Engl J Med. 1986;315:65. [PubMed] 76. Perez CM. Treatment of ciguatera poisoning with gabapentin. New Engl J Med. 2001;344:692–693. [PubMed] 77. Bourdy G. Traditional remedies used in the western Pacific for the treatment of ciguatera poisoning. J Ethnopharmacol. 1992;36:163–74. [PubMed] 78. Blythe DG. Mother’s milk turns toxic following fish feast. J Am Med Assoc. 1990;264:2074. [PubMed] 79. Lange WR. Can ciguatera be a sexually transmitted disease? . J Toxicol - Clin Toxicol. 1989;27:193–197. [PubMed] 80. Lange WR. Ciguatera toxicity. Am Fam Phys. 1987;35:177–182. [PubMed]
81. Lewis R. 5th Indo-Pacific Fish conference; Noumea, New Caledonia. 1999; pp. 739–744.
82. Ebesu J. Isolation and Characterization of Novel Ciguateric Compounds from Acanthurus Triostegus (Manini) University of Hawaii; 1998. Ph.D. Thesis.
83. Vernoux J-P. Ciguatera in the French West Indies. Memoires of the Queensland Museum. 1993;34:631–638.
84. Tosteson T. In: Sea surface temperature, benthic dinoflagellate toxicity and toxin transmission in the ciguatera food web. Reguera B, editor. Xunta de Galicia and IOC; 1998.
85. Villareal TA. Petroleum production platforms as sites for the expansion of ciguatera in the northwestern Gulf of Mexico. Harmful Algae. 2007;6:253–259.
86. Davin WT. Ciguatera toxins adversely affect piscivorous fishes. Trans Am Fish Soc. 1988;117:374–384.
87. Davin WT. Effects of ciguatera toxins on the bluehead. Trans Am Fish Soc. 1986;115:908–912.
88. Fleming LE. In: Harmful Algae. B Reguera JB, editor. Xunta de Galicia and Intergovernmental Oceanographic Commission of UNESCO; Santiago de Compostela (Spain): 1998. pp. 245–248.
89. Kirkpatrick B. International Conference on Harmful Algal bloom; Cape Town, South Africa. Nov 2004.
90. Fleming LE. Florida poison information center. University of Miami; Florida Department of Health; CDC; Childrens Hospital Cincinnati; Mote Marine Laboratory; Miami, FL: 2007.
91. Fleming LE. Oceans and human health: Emerging public health risks in the marine environment. Mar Poll Bull. 2006;53:545–560. [PMC free article] [PubMed]
92. Dewailly E. In: Oceans and Human Health: Risks and Remedies from the Sea. Walsh PJ, editor. Elsevier Science Publishers; New York, NY: in press.
93. Fleming LE. Evaluation of Harmful Algal Bloom Outreach Activities. Mar Drugs. 2007;5:208–219. [PMC free article] [PubMed] 94. Tsumuraya T. Production of monoclonal antibodies for sandwich immunoassay detection of ciguatoxin 51-hydroxyCTX3C. Toxicon. 2006;48:287–294. [PubMed] 95. Abraham WM. Effects of inhaled brevetoxins in allergic airways: toxin-allergen interactions and pharmacologic intervention. Environ Health Perspect. 2005;113:632–637. [PMC free article] [PubMed] 96. Anderson BS. The epidemiology of ciguatera fish poisoning in Hawaii, 1975–1981. Hawaii Med J. 1983;42:326–334. [PubMed] 97. Morris JG., Jr Clinical features of ciguatera fish poisoning: a study of the disease in the US Virgin Islands. Arch Int Med. 1982;142:1090–1092. [PubMed] 98. Czernichow P. [Epidemiology of Ciguatera in the Iles Saintes (Guadeloupe)] Rev Epidemiol Sante Pub. 1984;32:315–321. [PubMed] 99. Lewis ND. Disease and development: ciguatera fish poisoning. Soc Sci Med. 1986;23:983–993. [PubMed]
100. Luber G. Surveillance for ciguatera fish poisoning in Culebra, Puerto Rico. (in press)
101. McMillan J. Ciguatera fish poisoning in the United States Virgin Islands: preliminary studies. J Coll Virgin Is. 1980;6:84–107.
102. Holt RJ. An analysis of poison control center reports of ciguatera toxicity in Puerto Rico for one year. J Toxicol - Clin Toxicol. 1984;22:177–185. [PubMed] 103. Frennette C. A large common-source outbreak of ciguatera fish poisoning. J Infect Dis. 1988;158:1128–1131. [PubMed] 104. Engleberg NC. Ciguatera fish poisoning: a major common-source outbreak in the U.S. Virgin Islands. Ann Int Med. 1983;98:336–337. [PubMed]
105. Escalona de Motta G. Proc. 5th Intl Coral Reef Congress; Tahiti (French Polynesia). 1985; pp. 415–416.
106. Chateau-Degat ML. Neurologic signs of ciguatera disease: evidence of their persistence. Am J Trop Med Hyg. 2007;77:1170–1175. [PubMed]